4-甲氧基-α－溴代苯乙酮
4-甲氧基-α－溴代苯乙酮结构式
|
常用名 | 4-甲氧基-α－溴代苯乙酮 | 英文名 | PTP inhibitor 1 |
|---|---|---|---|---|
| CAS号 | 2632-13-5 | 分子量 | 229.071 | |
| 密度 | 1.4±0.1 g/cm3 | 沸点 | 306.7±17.0 °C at 760 mmHg | |
| 分子式 | C9H9BrO2 | 熔点 | 69-71 °C(lit.) | |
| MSDS | 中文版 美版 | 闪点 | 139.3±20.9 °C | |
| 符号 |
GHS05, GHS07 |
信号词 | Danger |
|
Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds.
J. Med. Chem. 54 , 4042-56, (2011) Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge. Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, being one of the inhibitors on clinical trials for different ta... |
|
|
QSAR study and conformational analysis of 4-arylthiazolylhydrazones derived from 1-indanones with anti-Trypanosoma cruzi activity.
Eur. J. Pharm. Sci. 78 , 190-7, (2015) A set of 4-arylthiazolylhydrazones derived from 1-indanones (TZHs) previously synthesized and assayed against Trypanosoma cruzi, the causative agent of Chagas disease, were explored in terms of conformational analysis. We found that TZHs can adopt four minimu... |
|
|
Synthesis of diblock copolymers bearing p-methoxyphenacyl side groups.
Polym. Chem. 2(10) , 2284-2292, (2011)
|